California’s Division of Workers’ Compensation (CA DWC) issued an update to the Physician and Non-Physician Practitioner portion of the state fee schedule for workers’ compensation.
The update adds 61 new Healthcare Common Procedure Coding System (HCPCS) codes, effective for all service dates on or after October 1, 2025.
The update conforms the fee schedule to the relevant 2025 Medicare changes, as California Labor Code Section 5307.1 requires. The CA DWC announced the update in a recent Newsline, and posted the order adopting the update on the CA DWC website.
daisyBIll clients do not need to take any action. Our billing software will automatically apply the changes for all dates of service on or after October 1. We advise non-daisyBill providers to adjust their systems appropriately.
Read on for details!
Below are the 61 new HCPCS codes the CA DWC (and Medicare) adopted for Q4 2025.
Note that when Medicare does not assign an HCPCS code a Relative Value Unit (RVU), providers calculate the reimbursement “By Report” (BR). California Code of Regulations Section 9789.12.4 provides specific guidelines for calculating BR code reimbursement rates.
HCPCS |
Description |
Reimbursement Calculation |
A2036 |
Cohealyx col dml mx pr sq cm |
By Report |
A2037 |
G4derm plus, per ml |
By Report |
A2038 |
Marigen pacto, per sq cm |
By Report |
A2039 |
Innovamatrix fd, per sq cm |
By Report |
A4288 |
Replacement breastpump valve |
By Report |
A9612 |
Inj, fluorescein, 1 mg |
By Report |
A9616 |
Gallium gozellix 1 millicuri |
By Report |
J0163 |
Epinephrine in nacl (endo) |
By Report |
J0164 |
Epinephrine in nacl (baxter) |
By Report |
J0458 |
Aztreonam/avibactam 10 mg |
By Report |
J0462 |
Atropine sulf, nte, 0.01 mg |
By Report |
J0525 |
Inj cefotetan disodium 10 mg |
By Report |
J0570 |
Buprenorphine implant 74.2mg |
By Report |
J0582 |
Bivalirudin (endo) 1 mg |
By Report |
J0614 |
Inj, treosulfan, 50 mg |
By Report |
J0668 |
Instill, bupivac and meloxic |
By Report |
J0675 |
Inj, carboprost, 0.1 mg |
By Report |
J0681 |
Inj ceftobipole medocarl 3mg |
By Report |
J0738 |
Hiv prep, inj, lenacapavir |
By Report |
J0752 |
Hiv prep, oral lenacapavir |
By Report |
J0759 |
Inj, clevidepine, 1 mg |
By Report |
J1370 |
Inj, esomeprazole sod, 1 mg |
By Report |
J1612 |
Inj glucagon (gvoke) 0.01 mg |
By Report |
J1807 |
Inj, ethacrynate sod, 1 mg |
By Report |
J1809 |
Inj, fosdenopterin, 0.1mg |
By Report |
J1834 |
Inj, isoniazid, 1 mg |
By Report |
J2151 |
Inj, mannitol, 250 mg |
By Report |
J2291 |
Inj, nafcillin (baxter) 20mg |
By Report |
J3290 |
Inj, tranexamic acid 5 mg |
By Report |
J3402 |
Inj. remestemcel-l-rknd/ td |
By Report |
J3403 |
Revakinagene, per implant |
By Report |
J7173 |
Inj. concizumab-mtci, 0.5 mg |
By Report |
J7174 |
Injection fitusiran 0.04 mg |
By Report |
J9011 |
Datopotamab deruxtecan, 1 mg |
By Report |
M0235 |
Intrav inf, mon anti, fir do |
By Report |
M0236 |
Intrav inf, mon anti, sec do |
By Report |
M0237 |
Intrav inf, toci, first dose |
By Report |
M0238 |
Intrav inf, toci, second dos |
By Report |
Q0235 |
Inj, monoclon antibody, 1 mg |
By Report |
Q0237 |
Inj, tocilizumab-anoh, hospi |
By Report |
Q4383 |
Axolotl graft ult per sq cm |
By Report |
Q4384 |
Axolotl dual ult per sq cm |
By Report |
Q4385 |
Apollo ft per sq cm |
By Report |
Q4386 |
Acesso trifaca per sq cm |
By Report |
Q4387 |
Neothelium ft per sq cm |
By Report |
Q4388 |
Neothelium 4l per sq cm |
By Report |
Q4389 |
Neothelium 4l+ per sq cm |
By Report |
Q4390 |
Ascendion per sq cm |
By Report |
Q4391 |
Amnioplast double per sq cm |
By Report |
Q4392 |
Grafix duo per sq cm |
By Report |
Q4393 |
Surgraft ac per sq cm |
By Report |
Q4394 |
Surgraft aca per sq cm |
By Report |
Q4395 |
Acelagraft per sq cm |
By Report |
Q4396 |
Natalin per sq cm |
By Report |
Q4397 |
Summit aaa per sq cm |
By Report |
Q5154 |
Inj, omlyclo, 5 mg |
By Report |
Q5155 |
Inj, aflibercept-jbvf, 1 mg |
By Report |
Q5156 |
Inj, tocilizumab-anoh, 1 mg |
By Report |
Q5157 |
Inj, denosumab-bmwo, 1 mg |
By Report |
Q5158 |
Inj, denosumab-bnht, 1 mg |
By Report |
Q5159 |
Inj, denosumab-dssb, 1 mg |
By Report |
Again, all bills providers submit via daisyBill will automatically reflect the most current, accurate fee schedule rates. If you have any questions regarding this update, use the chat function at the bottom right of this screen or email our experts at info@daisybill.com.
DaisyBill provides content as an insightful service to its readers and clients. It does not offer legal advice and cannot guarantee the accuracy or suitability of its content for a particular purpose.